Ry Frank
Ry Frank
Stop FollowingRy Frank
View as an RSS Feed
View Ry Frank's Articles BY TICKER:
ABT,
ABX,
AGNC,
ALU,
AMZN,
APA,
APC,
ARNA,
AZN,
BAC,
BBRY,
BHP,
BIDU,
BP,
CHK,
CIM,
COG,
COP,
COST,
CSCO,
CTL,
CVX,
CYS,
DNDN,
DVN,
EMC,
EOG,
ESV,
F,
FB,
FCX,
FFIV,
FSLR,
GE,
GG,
GM,
GOOG,
GSK,
HES,
HPQ,
INTC,
JNJ,
KERX,
KOG,
LMT,
MCD,
MO,
MRK,
MSFT,
MU,
NBL,
NFLX,
NFX,
NLY,
NOK,
ORCL,
OXY,
PEP,
PFE,
QCOR,
RIO,
S,
SBUX,
SD,
SIRI,
SNY,
SSNLF.PK,
T,
USB,
VRTX,
VRX,
VVUS,
VZ,
WFC,
WIN,
WMT,
XOM,
YHOO
- Buy This Retail King Now, Skip These 2
- 2 Solid Financial Stocks To Ride Higher In 2013
- Mongolia A Big Boost For Rio Tinto
- Mid-June Conference Reveals New Life For Bank Of America
- Noble: Israel's Energy Needs Will Spur Growth
-
Buffett's mREIT Entry Will Impact These 6 Stocks
-
Occidental: Don't Ignore This Lucrative E&P Stock
- Barrick: Buy Only At This Price
- 2 Big Pharma Stocks To Buy Before Eli Lilly
-
SandRidge: Buy Now To Beat Energy Sector Volatility
-
This Oil & Gas Stock Could Jump $28 By 2013
-
Nokia: Start Of A Comeback?
- AstraZeneca Will Soar On 2 New Drugs In 2013
- Will Intel Leap On These New Projects?
-
EMC: Don't Miss This Long-Term Growth Play
- Abbott A Safe Bet In A Volatile Pharma Sector
- Merck: Buy Now And Ride $4 Higher In 2013
- Netflix: Open Connect Will Likely Fail
- Oracle: Litigation Won't Dog Stock
- Nokia's Red Flags Could Tank Stock
- Zoetis Spin-Off Could Be Big For Pfizer
- First Solar: Don't Sell
- GlaxoSmithKline Could Slip On Recent Events
- Profit From 2 Obesity-Focused Biotech Stocks Now
- Why HP Could Be A $30 Stock By 2013
- Sirius: Risks Outweigh Rewards
- New Reasons Ford Could Make You Money By 2013
- Buy These 2 Oil & Gas Companies, Avoid BP
- Microsoft's SmartGlass May Be New Gold Mine
- Chesapeake: 'Third Scenario' Could Be Huge For Investors
- 41% Spike Possible On Glaxo's New Diabetes Drug
- Cash In On Oracle's Social Media Rush Now
